- Home
- CZR vs AXSM Comparison
CZR vs AXSM Comparison
Compare CZR & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZR
- AXSM
- Stock Information
- Founded
- CZR 1937
- AXSM 2012
- Country
- CZR United States
- AXSM United States
- Employees
- CZR N/A
- AXSM N/A
- Industry
- CZR Hotels/Resorts
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- CZR Consumer Discretionary
- AXSM Health Care
- Exchange
- CZR Nasdaq
- AXSM Nasdaq
- Market Cap
- CZR 5.4B
- AXSM 5.1B
- IPO Year
- CZR 1989
- AXSM 2015
- Fundamental
- Price
- CZR $29.87
- AXSM $105.60
- Analyst Decision
- CZR Strong Buy
- AXSM Strong Buy
- Analyst Count
- CZR 13
- AXSM 16
- Target Price
- CZR $44.00
- AXSM $170.50
- AVG Volume (30 Days)
- CZR 5.4M
- AXSM 694.5K
- Earning Date
- CZR 07-29-2025
- AXSM 08-04-2025
- Dividend Yield
- CZR N/A
- AXSM N/A
- EPS Growth
- CZR N/A
- AXSM N/A
- EPS
- CZR N/A
- AXSM N/A
- Revenue
- CZR $11,297,000,000.00
- AXSM $432,157,000.00
- Revenue This Year
- CZR $3.33
- AXSM $62.84
- Revenue Next Year
- CZR $2.50
- AXSM $60.02
- P/E Ratio
- CZR N/A
- AXSM N/A
- Revenue Growth
- CZR N/A
- AXSM 72.16
- 52 Week Low
- CZR $21.40
- AXSM $72.21
- 52 Week High
- CZR $45.93
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- CZR 58.17
- AXSM 48.53
- Support Level
- CZR $28.09
- AXSM $99.75
- Resistance Level
- CZR $29.81
- AXSM $106.60
- Average True Range (ATR)
- CZR 0.98
- AXSM 3.11
- MACD
- CZR 0.22
- AXSM 0.10
- Stochastic Oscillator
- CZR 88.12
- AXSM 44.39
About CZR Caesars Entertainment Inc.
Caesars Entertainment includes about 50 domestic gaming properties across the Las Vegas (49% of 2024 EBITDAR before corporate expenses) and regional (46%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2024. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.